BioNTech SE (BNTX)

Healthcare · Biotechnology · NASDAQ

BioNTech SE (BNTX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $23.53B and a free-cash-flow yield of -1.5%. Over the most recent reported fiscal year, revenue grew 4.3%.

Market cap	$23.53B
Trailing P/E	—
FCF yield	-1.5%
Revenue growth (YoY)	+4.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live BNTX data on Nama Insights →

Recent Congressional trades

BioNTech SE trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Josh Gottheimer	House	Buy	$1,001 - $15,000	Jan 4, 2024